REVIAN’s Sales Leadership Boost Signals Growth in Aesthetic Tech
Morrisville, N.C. – February 18, 2026 – REVIAN Inc., a leader in aesthetic medical technology specializing in light therapies for hair and skin rejuvenation, announced the promotion of Amy Keish to Senior Vice President of Sales. This move underscores the company’s commitment to expanding its reach in both the U.S. And international markets.
Scaling for Success: Keish’s Role at REVIAN
Amy Keish’s promotion recognizes her pivotal role in REVIAN’s commercial growth. She has been instrumental in scaling the company’s physician-focused sales organization and forging deeper partnerships with practices specializing in dermatology, aesthetics, and hair restoration. In her new role, Keish will continue to spearhead national sales strategy, field execution, and partner engagement.
According to John Oakley, Chief Executive Officer of REVIAN, Keish has been “instrumental in building a disciplined, high-performing sales organization aligned with the needs of our physician partners.” Her leadership and understanding of the aesthetic medical landscape have directly contributed to the company’s momentum.
The Rise of Light Therapy in Aesthetic Medicine
REVIAN’s success is tied to the growing adoption of its dual-wavelength LED technology. The company utilizes a patented combination of two wavelengths of light to stimulate nitric oxide production, increasing local blood flow, reducing inflammation, and inhibiting DHT production – creating an optimal environment for hair growth. REVIAN’s technology is cleared for apply in treating androgenetic alopecia in both men and women, addressing various patterns of hair loss and skin types I-IV.
Expanding Market Reach: A Look at the Bigger Picture
The promotion of Keish follows a period of sustained growth for REVIAN, reflecting a broader trend in the aesthetic medical technology market. Increasing consumer demand for non-invasive treatments, coupled with advancements in light-based therapies, are driving market expansion. REVIAN’s focus on partnering with healthcare providers and delivering science-backed results positions it well to capitalize on this growth.
Previously, in November 2025, REVIAN bolstered its sales leadership team with the appointments of Brenda Miller as Regional Director for the Central region and Bryan Hagen as Regional Director for the East region, further demonstrating the company’s investment in commercial infrastructure.
What’s Next for REVIAN?
Keish expressed her enthusiasm for the future, stating, “REVIAN is at an exciting inflection point. I’m proud of what our team has built and energized by the opportunity to continue scaling conscientiously whereas expanding into new markets.” This suggests a continued focus on strategic growth, both domestically and internationally.
Frequently Asked Questions
- What is REVIAN’s core technology? REVIAN utilizes precise wavelengths of LED light to rejuvenate hair and skin.
- What conditions does REVIAN’s technology treat? It is cleared for use in treating androgenetic alopecia in both men and women.
- Who is Amy Keish? Amy Keish is the Senior Vice President of Sales at REVIAN, responsible for national sales strategy and partner engagement.
Learn more about REVIAN’s innovative light therapies at www.revian.com
